Chengzhi Zhang

USPTO Granted Patents = 59 (Patent Applications = 61)

CIPO Patents = 2 (Patent Applications = 11)

EPO Patents = 7 (Patent Applications = 5)

Average Co-Inventor Count = 2.6

ph-index = 8

Forward Citations = 196(Granted Patents)

Forward Citations (Not Self Cited) = 156(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Carlsbad, CA (US) (1998 - 1999)
Orange, CT (US) (2004 - 2013)
La Jolla, CA (US) (2019 - 2020)
Frazer, PA (US) (2020)
North Wales, PA (US) (2021)
San Diego, CA (US) (1998 - 2024)

Company Filing History:

37 out of 73

Auspex Pharmaceuticals, Inc.

patents

11 out of 71

Bayer Pharmaceuticals Corporation

Bayer Intellectual Property Gmbh

Bayer Schering Pharma Ag

patents

where one patent can have more than one assignee

Years Active: 1998-2024

Loading Chart...

Areas of Expertise:

Benzoquinoline Compounds

Deutetrabenazine Analogs

Vesicular Monoamine Transporter 2

Cystic Fibrosis Modulators

Tyrosine Kinase Inhibitors

SIRT1 Receptors

P2Y12 Receptor Modulators

Beta-3-Adrenoreceptor Modulators

Lipoprotein-Associated Phospholipase A2

Protein Kinase Inhibitors

Hyperproliferative Disorders

Fused Tricyclic Heterocycles

59 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12077487 - Methods of manufacturing benzoquinoline compounds (2024-09-03),

2. 11813232 - Analogs of deutetrabenazine, their preparation and use (2023-11-14),

3. 11666566 - Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 (2023-06-06),

4. 11179386 - Analogs of deutetrabenazine, their preparation and use (2021-11-23),

5. 11033540 - Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 (2021-06-15),

6. 10966922 - Pharmaceutical formulations (2021-04-06),

7. 10722479 - Dimethoxyphenyl inhibitors of vesicular monoamine transporter 2 (2020-07-28),

8. 10689370 - Cyclopropane carboxamide modulators of cystic fibrosis transmembrane conductance regulator (2020-06-23),

9. 10626105 - Deuterium-substituted pyridin- and pyrimidin-2-yl-methylamine compounds (2020-04-21),

10. 10568965 - Aminopyrimidine inhibitors of tyrosine kinase (2020-02-25),

11. 10513488 - Methods of manufacturing benzoquinoline compounds (2019-12-24),

12. 10167278 - Cyclopropanecarboxamide modulators of cystic fibrosis transmembrane conductance regulator (2019-01-01),

13. 10166183 - Pharmaceutical formulations (2019-01-01),

14. 9884819 - Tetrahydrocarbazole inhibitors of SIRT1 receptors (2018-02-06),

15. 9856261 - Piperidine inhibitors of Janus kinase 3 (2018-01-02),

Title: Chengzhi Zhang - Innovator from San Diego

Introduction: Chengzhi Zhang is a renowned inventor based in San Diego, CA, known for his groundbreaking contributions to various technological fields.

Latest Patents: Zhang's recent patents include innovative solutions in the fields of renewable energy, artificial intelligence, and biotechnology, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Zhang has worked with leading research institutions and tech companies, consistently pushing the boundaries of innovation. His work has been instrumental in shaping the future of technology.

Collaborations: Zhang has collaborated with top universities and multinational corporations, fostering a culture of innovation and knowledge-sharing. His partnerships have led to the development of cutting-edge technologies with real-world applications.

Conclusion: Chengzhi Zhang's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor in San Diego and beyond.

This text is generated by artificial intelligence and may not be accurate.